Vor Ort
Merkzettel Warenkorb

Gutscheinbedingungen

**Gültig bis 15.06.2026 auf Spiele & Spielzeug online auf thalia.at, in der Thalia App ab einem Mindestbestellwert von 30€ und in allen Thalia Buchhandlungen in Österreich. In den Buchhandlungen nur gültig auf lagernde Ware. Einzelne Artikel können ausgeschlossen sein. Ausgenommen sind preisgebundene Artikel sowie online auf thalia.at und in der Thalia App einzelne Artikel von tonies®. Pro Einkauf einmal einlösbar. Nur gültig gegen Vorlage oder im Onlineshop hinterlegter Bonuscard. Infos zur Einlösung in der Buchhandlung sind auf der Bonuscard-Vorteilspreisseite zu finden. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Einlösung bei Scan & Go-Bezahlung. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Geschenkkarten, Versandkosten und Services.
  • Produktbild: PCR: Clinical Diagnostics and Research
  • Produktbild: PCR: Clinical Diagnostics and Research
- 11%

PCR: Clinical Diagnostics and Research

Aus der Reihe Springer Lab Manuals
11% sparen

96,99 € UVP 109,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.12.2011

Verlag

Springer Berlin

Seitenzahl

367

Maße (L/B/H)

28/21/2,2 cm

Gewicht

964 g

Auflage

Softcover reprint of the original 1st ed. 1992

Sprache

Englisch

ISBN

978-3-642-77494-2

Beschreibung

Rezension

"an authoratative and comprehensive book on the subject...anyone contemplating introducing the method into a clinical laboratory would find this book invaluable" British Journal of Biomedical Science

"This book will provide valuable information to all those using PCR." - General Pharmacology

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.12.2011

Verlag

Springer Berlin

Seitenzahl

367

Maße (L/B/H)

28/21/2,2 cm

Gewicht

964 g

Auflage

Softcover reprint of the original 1st ed. 1992

Sprache

Englisch

ISBN

978-3-642-77494-2

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern
  • Produktbild: PCR: Clinical Diagnostics and Research
  • Produktbild: PCR: Clinical Diagnostics and Research
  • 1. PCR: principles and reaction components.- 1.1. PCR: A cyclic, exponential, in vitro amplification process.- 1.2. Temperature and time profile of thermal cycling.- 1.2.1. Initial denaturation.- 1.2.2. Primer annealing.- 1.2.3. Primer extension.- 1.2.4. Denaturation step.- 1.2.5. Cycle number.- 1.2.6. Final extension.- 1.3. Taq DNA polymerase and reaction buffer.- 1.4. Deoxynucleotide triphosphates (dNTPs).- 1.5. Primers.- 1.5.1. Primer-related PCR artifacts.- 1.5.2. Melting temperature (Tm) and optimized annealing temperature.- 1.5.3. Primer concentration.- 1.6. Oil overlay and reaction volume.- 1.7. DNA sample.- 1.7.1. Purity of samples.- 1.7.2. Homogeneity of samples.- 1.7.3. DNA content of samples.- 1.8. Size and structure of amplification products.- 1.9. PCR set-up strategies.- Method: Mastermix PCR.- 2. Optimization strategies.- 2.1. Analytical PCR.- 2.1.1. Specificity.- 2.1.2. Product analysis (agarose gel) and trouble-shooting.- 2.1.3. Sensitivity.- 2.2. Preparative PCR.- 2.2.1. Reamplification.- 2.2.2. Incorporation of label using Taq polymerase.- Method 1: Reamplification of PCR products 29 Method 2: PCR synthesis of double- and single-stranded probes.- 3. General applications of PCR.- 3.1. Asymmetric PCR.- 3.2. Allele-specifîc amplification (ASA).- 3.3. Nested PCR.- 3.4. Multiplex PCR.- 3.5. Differential PCR.- 3.6. Competitive PCR.- 3.7. Amplification of unknown sequences.- 3.8. Application of PCR for genetic examinations, DNA amplification fingerprinting.- 3.9. Amplification with consensus primers.- 3.10. Expression PCR.- 3.11. Detection of infectious agents or rare sequences.- 4. Substances affecting PCR: Inhibition or enhancement.- 4.1. Inhibition introduced by native material.- 4.1.1. Blood.- 4.1.2. Fixed paraffin-embedded tissue.- 4.2. Inhibition introduced by reagents during DNA isolation: Detergents, Proteinase K and Phenol.- 4.2.1. Detergents.- 4.2.2. Proteinase K.- 4.2.3. Phenol.- 4.2.4. Salts and buffer systems.- 4.3. Additives influencing the efficiency of PCR.- 4.3.1. Dimethyl sulfoxide (DMSO).- 4.3.2. Glycerol.- 4.3.3. Formamide.- 4.3.4. Polyehtylene glycol (PEG).- 4.3.5. TWEEN.- 4.4. Evaluation of the effect of individual additives.- Method: Improving the efficiency of PCR amplification of HIV-1-provirus DNA from patient samples using a panel of additives.- 5. PCR: Contamination and falsely interpreted results.- 5.1. Control experiments.- 5.2. Sources of contaminations.- 5.2.1. Pre-PCR contaminations.- 5.2.2. Post-PCR contaminations.- 5.3. Prevention and elimination of contamination.- 5.3.1. Laboratory architecture.- 5.3.2. Autoclave.- 5.3.3. Working place and equipment.- 5.3.4. Influence of contamination risks on experimental design.- 5.3.5. Decontamination procedures.- 5.3.6. Chemical modification of PCR products to prevent carryover.- 6. Biological material amenable to PCR.- 6.1. Sample preparation and storage.- 6.1.1. Peripheral blood leucocytes.- Method 1: Selective lysis of red blood cells.- Method 2: Buffy coat.- Method 3: Isolation of mononuclear cells using FICOLL-PAQUE™.- 6.1.2. Pharyngeal and mouthwashes.- 6.1.3. Sputum, bronchoalveolar fluids.- Method 4: Preparation of mycobacterial DNA from sputum.- 6.1.4. Cerebrospinal fluid.- 6.1.5. Urine.- 6.1.6. Plasma, serum and other samples without host cellular DNA.- 6.1.7. Biopsies and solid tissue samples.- 6.1.8. Formalin-fixed, paraffin-embedded tissue.- 7. Isolation of DNA from cells and tissue for PCR.- 7.1. Alkaline lysis.- Method 1: Isolation of DNA using alkaline lysis.- 7.2. Guanidinium rhodanid method (GuSCN).- 7.3. Proteinase K digestion for the isolation of DNA.- Method 2: Proteinase K/phenol-chloroform extraction.- Method 3: PCR-adapted proteinase K method for leucocytes or whole blood.- Method 4: DNA isolation from paraffin-embedded tissue.- Method 5: Detection of viral DNA from serum.- 7.4. Automated DNA extraction.- 8. Isolation of RNA from cells and tissue for PCR.- 8.1. General preparations.- 8.2. Inhibition of endogenous RNases.- 8.3. Methods for the isolation of RNA suitable for RT-PCR.- Method 1: Acid guanidinium thiocyanate-phenol-chloroform extraction.- Method 2: Microadaption of the guanidinium-thiocyanate/CsCl ultracentrifugation method.- Method 3: Quick RNA isolation.- 9. Reverse transcription/PCR (RT-PCR).- 9.1. Setting up an RT-PCR.- 9.2. Selective RT-PCR.- Method 1: RNase-free DNase treatment of RNA samples.- Method 2: Reverse transcriptase using MoMLV-RT.- 10. Methods for identification of amplified PCR products.- 10.1. Agarose gel electrophoresis.- 10.1.1. Electrophoresis equipment.- 10.1.2. Gel loading buffer (GLB).- 10.1.3. UV-illumination and photography of stained gels.- 10.1.4. Molecular weight markers and semiquantitative gel analysis.- Method 1: Agarose gel casting.- Method 2: Post-PCR sample loading.- 10.2. DNA blot transfer and nonradioactive hybridization /detection.- 10.2.1. Capillary transfer (Southern blot).- Method 3: Southern blot from agarose gels.- 10.2.2. Dot blot and slot blot procedures.- Method 4: Dot blot protocol.- 10.2.3. Hybridization with digoxigenin-11-dUTP labeled DNA probes.- Method 5: Membrane hybridization procedure.- 10.3. Detection systems of digoxigenin labeled hybrids.- Method 6: Chromogen detection (NBT/BCIP).- Method 7: Chemiluminescence detection (AMPPD™).- 10.4. Polyacrylamide gel (PAGE) electrophoresis.- 10.4.1. Separation of radioactive labeled amplification products and autoradiography.- Method 8: Vertical denaturing Polyacrylamide gel.- 10.4.2. Detection of non-radioactive amplification products in PAGE using silver stain.- Method 9: Silver stain of denaturing PAGE.- 11. Restriction fragment analysis.- 11.1. Restriction endonucleases.- 11.2. Endonuclecase selection.- 11.3. Optimal digestion conditions.- Method: Restriction digest of PCR products.- 12. Multiplex PCR.- Method: Detection of three different mycobacterial genom regions in a single PCR tube.- 13. Detection of single base changes using PCR.- 13.1. Allele-specific amplification (ASA, PASA, ASP, ARMS).- 13.2. Allele-specific oligonucleotide hybridisation (ASO).- Method 1: Oligonucleotide hybridization using TMAC1 buffer.- 13.3. Chemical mismatch cleavage method.- Method 2: Chemical cleavage of mismatches in PCR products.- 13.4. Denaturing gradient gel electrophoresis (DGGE).- Method 3: Denaturing gradient gel elctrophoresis.- 13.5. PCR single-strand conformation polymorphism (PCR-SSCP).- Method 4: Sngle-strand conformation polymorphism (SSCP).- 14. Non-radioactive, direct, solid-phase sequencing of genomic DNA obtained from PCR.- 14.1. Generation of single-stranded DNA fragments.- 14.2. Sequencing of biotinylated PCR products.- Method 1: Manual sequencing procedure.- Method 2: Automatic sequencing procedure.- 15. Application of PCR to analyze unknown sequences.- 15.1. Inverse PCR.- Method 1: Inverse PCR.- 15.2. Alternative methods to inverse PCR.- 15.2.1. “Alu-PCR”.- 15.2.2. Targeted gene walking PCR.- 15.2.3. “Panhandle PCR”.- 15.2.4. Rapid amplification of cDNA ends (RACE-PCR).- Method 2: Rapid amplification of 3?cDNA ends (3?-RACE).- Method 3: Rapid amplification of 5?cDNA ends (5?-RACE).- 16. Quantification of PCR-products.- 17. Cloning methods using PCR.- Method: Cloning and purification of a partial gag-sequence of HIV-1 using PCR.- 18. Site-directed mutagenesis using the PCR.- 19. In-situ polymerase chain reaction.- 20. Oligonucleotides in the field of PCR.- 20.1. Guidelines for designing PCR primers.- 20.2. Synthesis of primers.- 20.3. Purification of oligonucleotides.- Method 1: Purification of oligonucleotides by gel electrophoresis.- Method 2: Purification of oligonucleotides by reverse-phase HPLC.- Method 3: Quick purification of oligonucleotides using anion-exchange.- columns (01igoPak™).- 20.3. Chemical modification of primers.- Method 4: Labelling of oligonucleotides by T4polynucleotide kinase.- Method 5: Chemical labelling of oligonucleotides using photoactive biotin.- Method 6: 3?-end biotin labelling by terminal deoxynucleotidyl transferase.- Method 7: Modifications of the 3?terminus with a primary aliphatic amine.- Method 8: 5?-end labelling by an amino linker during synthesis.- Method 9: 5?-end labelling by introduction of a sticky-and restriction site in the PCR with subsequent incorporation by Klenow polymerase.- 21. Review of different heat-stable DNA polymerases.- 21.1. Taq DNA polymerase.- 21.2. Vent polymerase (Thermococcus litoralis).- 21.3. Thermus thermophilus DNA polymerase.- 21.4. Pfu DNA polymerase (Pyrococcus furiosus).- Method: Amplification of a 365bp HIV-1-fragment using Pfu polymerase and influence of DMSO on amplification efficiency.- 21.5. Bst polymerase.- 21.6. Fidelity of different heat-stable DNA polymerases.- 22. Physical features of thermocyclers and of their influence on the efficiency of PCR amplification.- 23. Alternative methods to PCR.- 23.1. Ligase chain reaction (LCR).- 23.2. Transcription-based amplification system (TAS).- 23.3. Self-sustained sequence replication (3SR).- 23.4. Q-beta replicase.- Addendum: Methodological examples for the application of the Polymerase chain reaction.- A) Characterization of oncogenes.- Detection of mutations at codon 61 of the c-Ha-ras gene in small precancerous liver lesions of the C3H mouse R Bauer-Hofmann, A Buchmann, F Klimek, M Schwarz.- Isolation and direct sequencing of PCR-cDNA fragments from tissue biopsies H Klocker, F Kaspar, J Eberle, G Bartsch.- Differential PCR: Loss of the ?1-interferon gene in chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) A Neubauer, C Schmidt, B Neubauer, W Siegert, D Huhn, E Liu.- B) Detection of infectious agents.- Long-term persistence of Borrelia burgdorferi in neuroborreliosis detected by polymerase chain reaction S Bamborschke, A Kaufhold, A Podbielski, B Melzer, A Porr, B Rehse-Küpper.- Two-stage polymerase chain reaction for the identification of Borrelia burgdorferi in the tertiary stage of neuroborreliosis H Bocklage, R Lange, H Karch, J Heesemann, HW Kölmel.- Screening for CMV infection following bone marrow transplantation using the PCR technique H Einsele, M Steidle, M Müller, G Ehninger, JG Saal, CA Müller.- Detection of spumaviral sequences by polymerase chain reaction W Muranyi, R M Flügel.- The use of PCR for epidemiological studies of HNANB viruses in arthropod vectors R Seelig, CF Weiser, HW Zentraf, C Bottner, HP Seelig, M Renz.- C) Basic methodology and research applications.- In vitro amplification and digoxigenin labelling of single-stranded and double-stranded DNA probes for diagnostic in situ hybridization U Finckh, P A Lingenfelter, K W Henne, C Schmidt, W Siegert, D Myerson.- Differentiation of arylsulfatase A deficiencies associated with metachromatic leukodystrophy and arylsulfatase A pseudodeficiency V Gieselmann.- Molecular genetics of neuromuscular diseases — the role of PCR in diagnostics and research B Kadenbach, P Seibel.- The application of polymerase chain reaction for studying the phylogeny of bacteria G Köhler, W Ludwig, KH Schleifer.- Site-directed mutagenesis facilitated by PCR O Landt, U Hahn.- Ectopic transcription in the analysis of human genetic disease J Reiss.- Appendix I: Suppliers of specialist items.- Appendix II: List of Contributors.- Appendix III: DNA sequencing chrornato grams.